Dr. Joseph Goldberg, Clinical Professor at the Icahn School of Medicine at Mount Sinai and immediate past president of the American Society of Clinical Psychopharmacology (ASCP), shares insights from his remarkable career, from his beginnings in neuroscience to his influential leadership roles. Along the way, he explores the future of mental health, focusing on mentorship, innovative education, and translating research into patient-centered care.Throughout the episode, Dr. Goldberg recounts his unique journey into psychiatry, which began with studying frogs and led to a focus on bipolar disorder. He offers an insider’s view of the ASCP, detailing initiatives from his presidency, including task forces on ketamine and de-prescribing. A key highlight is ASCP’s revolutionary AI-enhanced "living textbook," a new approach to medical education designed to transform how clinicians learn about psychopharmacology, ensuring the latest knowledge is always accessible.Episode Highlights:00:00 - Introducing Dr. Joseph Goldberg, MD01:13 - From Frogs to Psychiatry: A Scientist’s Origin Story02:51 - Why Bipolar Became the Focus: Early Pharmacology Momentum04:20 - ASCP’s Patient-Centered Mission & Why It Became “Home”05:08 - Mentorship Pipeline: NCDEU Roots and Career Breaks08:10 - Leadership Model in Action & New President Anita Clayton11:17 - ASCP Task Forces: Ketamine/Esketamine and Deprescribing Guidance14:13 - CME 2.0 & AI “Living Textbook” (edYOU) for Psychopharm Education18:43 - Limbic Learning & Nasrallah Award: Make Education Stick20:18 - Early-Career Lift: Posters, Committees, New Investigator Awards23:18 - What’s Next in Psychopharm: Tangible Advances for Patients25:44 - ASCP × JCP Synergy & Membership Call to Action27:40 - Looking Ahead: Bridging Bench to Bedside with Future GuestsKey Takeaways:"The frogs brought me to med school, brought me to research in psychiatry and psychopharmacology, and, well, here I am today.""ASCP has always been my professional home, intellectually, scientifically, even socially.""It's really about the pragmatic translation of findings into clinical care, which just really spoke to my interest in the kind of 'so what' factor of what it is we do.""It's a living textbook in psychopharmacology, so it can be continually updated. We hope it's going to revolutionize the way we teach psychopharmacology.""Steve and I both call this 'limbic learning.' You remember things when they're presented in an impactful kind of way. It's almost like PTSD in reverse.""We live in a time and an era of true advances. We have things in our pharmacopeia now that did not exist 5 years ago.""This is a home. This is a place where I think you will find like-minded people. You'll make friends for life.""If you interact with ASCP or JCP, you will not ask the question, 'What does this have to do with my patients?'"Links: Full transcript and show notes: https://www.psychiatrist.com/jcp/ep2-clinical-psychopharmacology-joe-goldberg/ Journal of Clinical Psychiatry: psychiatrist.com/jcp/ Dr. Joseph Goldberg, MD: https://www.josephgoldbergmd.com/American Society of Clinical Psychopharmacology: https://ascpp.org/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related